ADMELOG

This brand name is authorized in United States. It is also authorized in Canada, South Africa.

Active ingredients

The drug ADMELOG contains one active pharmaceutical ingredient (API):

1	Insulin lispro UNII GFX7QIS1II - INSULIN LISPRO
	The primary activity of insulin lispro is the regulation of glucose metabolism.
	Read more about Insulin lispro

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ADMELOG Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10AB04	Insulin lispro	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AB Insulins and analogues for injection, fast-acting
Discover more medicines within A10AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02469871, 02469898, 02469901
US	FDA, National Drug Code	0024-5924, 0024-5925, 0024-5926, 70518-2399
ZA	Health Products Regulatory Authority	55/21.1/0094